Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....

PRISM MEDICO AND PHARMACY LIMITED CIN: L24100HP2002PLC009299; Email Id: investorgrievancewmcl@gmail.com Registered Office: Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. Date: 24.08.2026 To, T o, Department of Corporate Services, Listing Department, BSE LIMITED Metropolitan Stock Exchange of India Limited P. J. Towers, Dalal Street, (MSED © Mumbai, Maharashtra-400001. Vibgyor Towers, 4* Floor, Plot Number C 62, G - Block, Opposite Trident Hotel, Bandra Kurla Complex, ISIN : INE730E01016 Bandra (E), Mumbai, Maharashtra-400098. Scrip Code: 512217 SYMBOL: PRISMMEDI Subject: Annual Report for the Financial Year 2025-2026. Reference: Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Report of the company for the Financial Year 2025-2026. You are requested to kindly take the same on record and oblige. Thanking You. Yours Truly, FOR PRISM MEDICO AND PHARMACY LIMITED fi A Q) footy / Avlep yUte# ise a Sf : DAVENDER SINGH DIRECTOR DIN: 09447213 PRISM MEDICO PHARMACY LIMITED ANNUAL REPORT 2025-2026 1 | P age PRISM MEDICO AND PHARMACY LIMITED - AN OVERVIEW THE BOARD OF DIRECTORS STATUTORY AUDITOR Ms. Sakshi Laller, M/s. Garg Mendiratta & Associates Wholetime Director Chartered Accountants Mohali, Punjab. Mr. Davender Singh, Firm Registration Number: 016823N. Director CHIEF FINANCIAL OFFICER Mr. Dinesh Kumar, Independent Director Mr. Bharat Singh Mr. Pardeep Kumar, Independent Director COMPANY SECRETARY SECRETARIAL AUDITORS Mr. Sameer Gupta. M/s. SDK & Associates Company Secretaries, Chandigarh. CP Number: 24579. REGISTRAR AND TRANSFER AGENT BANKERS Purva Share Registry (India) Private Canara Bank. Limited SCO 56, Chandi Path, Sector 30C, Chandigarh- Unit Number 9, Shiv Shakti Industrial 160030. Estate, Ground Floor, J. R. Boricha Marg, Opposite Kasturba Hospital, Lower Parel, Mumbai, Maharashtra-400011. Email Id: support@purvashare.com Phone Number: 022-23016761 REGISTERED OFFICE STOCK EXCHANGE Suketi Road, Kala Amb, Sirmaur, Himachal 1. Bombay Stock Exchange Limited. Pradesh-173030. 2. Metropolitan Stock Exchange of India Website:www.prismmedico.in Limited. EMAIL ID: Scrip Code: 512217 investorgrievancewmcl@gmail.com ISIN Equity Share: INE730E01016 2 | P age CONTENTS 1. Notice to Members 4-27 2. Board’s Report and Annexure thereto 28-52 3. Auditor’s Report 53-60 4. Balance Sheet 61 5. Statement to Profit and Loss Account 62 6. Cash Flow Statement 63 7. Notes to Financial Statement 64-75 3 | P age NOTICE CONVENING THE 24TH ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN THAT THE 24TH ANNUAL GENERAL MEETING OF THE MEMBERS OF PRISM MEDICO AND PHARMACY LIMITED WILL BE HELD ON SATURDAY, THE 19TH DAY OF SEPTEMBER 2026, AT 12:30 P.M. THROUGH VIDEO CONFERENCING (VC)/OTHER AUDIO VISUAL MEANS (OAVM) FACILITY TO TRANSACT THE FOLLOWING BUSINESS:  ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Standalone Financial Statements of the company for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mr. Davender Singh (DIN: 09447213), who retires by rotation and being eligible, offers himself for re-appointment. 3. To consider and if thought fit, to pass, the following resolution as an Ordinary Resolution: To re-appoint M/s. Garg Mendiratta and Associates, Chartered Accountants as the statutory auditors of the company and fix their remuneration. “RESOLVED THAT pursuant to the provisions of Section 139, 141 and 142 and all other applicable provisions, of the Companies Act, 2013 (“the Act”) and Rules made there under (including any statutory modification(s) or re- enactment thereof for the time being in force), the consent and approval of the members of the company be and is hereby given for the re-appointment of M/s. Garg Mendiratta and Associates, Chartered Accountants as the statutory auditors of the company to hold the office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting to be held for the financial year 2026-2027 at such remuneration and all out of pocket expenses as may be decided between the Board of Directors and M/s. Garg Mendiratta and Associates, Chartered Accountants.” “RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorized to do all such acts, deeds and action as may be necessary, proper or expedient to give effect to this resolution.”  SPECIAL BUSINESS: 4. To consider and if thought fit, to pass, the following Resolution as an Ordinary Resolution: To appoint M/S. SDK & Associates, Practicing Company Secretaries as the Secretarial Auditors of the Company for a period of five financial years from financial year 2026-2027 to financial year 2030-2031. “RESOLVED THAT pursuant to the provision of Section 204 of the Companies Act, 2013, read with Rule 9 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), enactment(s) or re-enactment(s) thereof, for the time being in force) the consent and approval of the members of the company be and is hereby accorded for the appointment of M/s. SDK & Associates, Practicing Company Secretaries, a peer reviewed firm (Peer Review Certificate Number 7065/2025) as the Secretarial Auditors of the Company for a term of five consecutive financial years commencing from the financial year 2026-2027 to financial year 2030-2031, on such remuneration to be decided by the Board of Directors in consultation with Secretarial Auditors from time to time.” “RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorized to do all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give effect to this 4 | P age resolution.” 5. To consider and if thought fit, to pass, the following resolution as a Special Resolution: To approve variation in the objects of the Preferential Issue and in the utilisation of the proceeds thereof, as approved by the members at the Extraordinary General Meeting held on March 20, 2026. "RESOLVED THAT pursuant to the provisions of Sections 23, 42, 62 and all other applicable provisions, if any, of the Companies Act, 2013 ("the Act") read with the Rules made thereunder (including any statutory modification(s) or re-enactment thereof for the time being in force), the applicable provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended ("SEBI ICDR Regulations"), Regulation 32 and all other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time ("SEBI Listing Regulations"), the provisions of the Memorandum and Articles of Association of the Company, and subject to such other approvals, consents, permissions and sanctions as may be required, and on the recommendation of the Audit Committee and the Board of Directors, the consent and approval of the Members of the Company be and is hereby accorded to vary the objects of the preferential issue of 75,00,000 Equity Shares and 50,00,000 Convertible Warrants approved by the Members at the Extraordinary General Meeting held on March 20, 2026 (as modified by the Corrigendum to the said Notice dated March 18, 2026) and allotted by the Board of Directors on May 05, 2026, and the utilisation of the proceeds thereof, in the manner set out in the table below: S. No. Original Object (as per Original Revised Object Amount Revised allocation / Notice dated February 23, Allocation utilised till bal [Showing first 8,000 characters — download PDF for full document]